Brief: Hikma And Richter Receive FDA Approval For Denosumab Biosimilars Enobytm (Denosumab- Qbde) And Xtrenbotm (Denosumab- Qbde)

Hikma Pharmaceuticals

29/09/2025 07:45

Sept 29 (Reuters) - Hikma Pharmaceuticals PLC HIK.L:

HIKMA AND RICHTER RECEIVE FDA APPROVAL FOR DENOSUMAB BIOSIMILARS ENOBYTM (DENOSUMAB- QBDE) AND XTRENBOTM (DENOSUMAB- QBDE)

Further company coverage: HIK.L

 ((Reuters.Briefs@thomsonreuters.com;))